<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Ceva launches Tulaven for bovine respiratory disease.</title><link>/b/veterinary-news/posts/ceva-launches-tulaven-for-bovine-respiratory-disease</link><description> Ceva Animal Health has launched Tulaven 100mg/ml (tulathromycin) for bovine respiratory disease (BRD). 
 Tulaven is licensed for the treatment and metaphylaxis of BRD associated with Mannheimia haemolytica , Pasteurella multocida , Histophilus somni</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>